1. Cancer-targeted and glutathione-responsive micellar carriers for controlled delivery of cabazitaxel
   Xiaoxiong Han et al, 2019, Nanotechnology CrossRef
2. Integrins as attractive targets for cancer therapeutics
   Meng Li et al, 2021, Acta Pharmaceutica Sinica B CrossRef
3. Hepatic Sinusoid Capillarizate via IGTAV/FAK Pathway Under High Glucose
   Jia Liu et al, 2024, Applied Biochemistry and Biotechnology CrossRef
4. The Protective Effect of a Long-Acting and Multi-Target HM-3-Fc Fusion Protein in Rheumatoid Arthritis
   Ruijing Huang et al, 2018, International Journal of Molecular Sciences CrossRef
5. Disintegrin Tablysin-15 Suppresses Cancer Hallmarks in Melanoma Cells by Blocking FAK/Akt/ERK and NF-κB Signaling
   Zhenhui Deng et al, 2020, Current Cancer Drug Targets CrossRef
6. The anticancer properties and mechanism of action of tablysin-15, the RGD-containing disintegrin, in breast cancer cells
   Zhenhui Deng et al, 2019, International Journal of Biological Macromolecules CrossRef
7. Pathogenic role and therapeutic potential of pleiotrophin in mouse models of ocular vascular disease
   Weiwen Wang et al, 2017, Angiogenesis CrossRef
8. Combination Therapy of PEG-HM-3 and Methotrexate Retards Adjuvant-Induced Arthritis
   Jingchao Hao et al, 2017, International Journal of Molecular Sciences CrossRef
9. Extracellular fibrin promotes non-small cell lung cancer progression through integrin β1/PTEN/AKT signaling
   Guilong Li et al, 2023, Open Life Sciences CrossRef
10. Dermal mesenchymal stem cells promoted adhesion and migration of endothelial cells by integrin in psoriasis
    Qixin Han et al, 2021, Cell Biology International CrossRef